Kelly Palekar
Psychiatric/Mental Health · Milton, DENPI 1639560345
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,216 of the $5,177 with a category attached, or 81.4%. 24 manufacturers reported payments, led by Johnson & Johnson at 24.3% of the total. 2025 is the largest year on record at $2,058, 3.4 times the $611 reported in 2022. Among psychiatric/mental health clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $40.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Brainsway USA Inc$782
- Otsuka America Pharmaceutical, Inc.$422
- Alkermes, Inc.$300
- AbbVie$268
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$229
- plus $2K from 18 others
What the payments were for
- Travel & lodging$86017%
- Food & beverage$4,21681%
- Education$1012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $1,259 |
| Brainsway USA Inc | 2 | $782 |
| Otsuka America Pharmaceutical, Inc. | 11 | $422 |
| Alkermes, Inc. | 9 | $300 |
| AbbVie | 16 | $268 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $229 |
| Lundbeck LLC | 11 | $216 |
| AstraZeneca | 2 | $208 |
| Axsome Therapeutics, Inc. | 9 | $207 |
| Teva Pharmaceuticals USA, Inc. | 6 | $183 |
| Neurocrine Biosciences, Inc. | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $138 |
| Tris Pharma Inc | 8 | $138 |
| Novo Nordisk | 1 | $125 |
| Amgen | 1 | $120 |
| Ironshore Pharmaceuticals Inc. | 2 | $120 |
| Boehringer Ingelheim | 1 | $77 |
| Lilly USA, LLC | 1 | $71 |
| Sage Therapeutics, LLC | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Corium, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$913
- Brainsway Deep TMS System$732
- ARISTADA$480
- REXULTI$241
- BREZTRI$125
- Wegovy$125
- ARISTADA INITIO$120
- Prolia$120
- JORNAY PM$105
How this compares
$5,177 in reported general payments places this provider in the 90th percentile of 177 psychiatric/mental health providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 23 | $1,569 |
| Duloxetine Hcl | 16 | $1,176 |
| Buspirone Hcl | 48 | $578 |
| Escitalopram Oxalate | 34 | $413 |
| Lamotrigine | 22 | $325 |
| Quetiapine Fumarate | 14 | $292 |
| Trazodone Hcl | 32 | $287 |
| Sertraline Hcl | 44 | $274 |
| Mirtazapine | 25 | $212 |
| Bupropion XlBupropion Hcl | 14 | $201 |
| Fluoxetine Hcl | 12 | $72 |
| Lorazepam | 20 | $63 |
| Clonazepam | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Milton
- Susan CoreyMilton$5K
- Ronald TyreeWilmington$59K
- Ericka Taylor-DanielDover$39K
- Cindy CunninghamDover$14K
- Kameka HartNewark$10K
- Jenika MilesWilmington$8K
- Catherine DotyNewport$7K
- Stephanie McKayWilmington$6K
- Bradley WhyNewark$6K
- Jacqueline ArmstrongWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.